ERBB2 and glioblastoma: proved that TanCAR T cells showed the best anti‐tumor ability by targeting HER2 and IL‐13α2 in the glioblastoma model, followed by targeted CAR‐T cells and finally mixed CAR‐T cells [61, 73].